Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma Clin Cancer Res
Resistance to PI3κδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis Haematologica
Functional specialization of different PI3K isoforms for the control of neuronal architecture, synaptic plasticity, and cognition Sci Adv
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial Lancet Haematol
Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia LEUKEMIA RES
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients J Clin Med
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry BONE MARROW TRANSPL